Media formats available:
Recommended
- ACC.24
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
- Kidney DiseaseA multidisciplinary approach to managing potassium levels in patients with HF when optimizing RAASi therapy
Antoni Bayés-Genís, MD, PhD
Patrick Rossignol, MD, PhD
- ESC Congress 2023Effect of SGLT2i on diuretic efficacy in acute heart failure
- ESC Congress 2023Inorganic nitrate reduces risk of contrast-induced nephropathy after coronary angiography
Dan Jones, MD, PhD